B
The Procter & Gamble Company
PG
NYSE
$146.69 -$2.33-1.56% Volume3,337,134 11/30/2021 1:19PM Eastern Quotes delayed
Recommendation
Prev Close
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)
B
Buy 10/21/2021Downgrade
The Procter & Gamble Company (PG) was downgraded to B from B+ on 10/21/2021 due to a decline in the solvency index, valuation index and total return index. The quick ratio declined from 0.45 to 0.44, and debt to equity increased from 0.71 to 0.72.
B
Buy 10/6/2021Upgraded
The Procter & Gamble Company (PG) was upgraded to B+ from B on 10/6/2021 due to a large increase in the volatility index, growth index and solvency index. EBIT increased 23.46% from $3.79B to $4.67B, total revenue increased 4.62% from $18.11B to $18.95B, and operating cash flow increased 0.83% from $4.09B to $4.12B.
B
Buy 9/2/2020Upgraded
The Procter & Gamble Company (PG) was upgraded to B from B- on 9/2/2020 due to a noticeable increase in the total return index and volatility index.
B
Buy 8/7/2020Upgraded
The Procter & Gamble Company (PG) was upgraded to B- from C on 8/7/2020 due to a significant increase in the growth index, valuation index and solvency index. Operating cash flow increased 18.26% from $4.06B to $4.81B, debt to equity declined from 0.81 to 0.77, and total revenue increased 2.81% from $17.21B to $17.7B.
C
Hold 8/8/2019Downgrade
The Procter & Gamble Company (PG) was downgraded to C from B- on 8/8/2019 due to a significant decline in the valuation index, growth index and solvency index. Earnings per share declined from $1.0407 to -$2.1942, debt to equity increased from 0.56 to 0.65, and the quick ratio declined from 0.53 to 0.51.
B
Buy 4/25/2019Downgrade
The Procter & Gamble Company (PG) was downgraded to B- from B on 4/25/2019 due to a decline in the volatility index, growth index and dividend index. EBIT declined 17.74% from $4.06B to $3.34B, earnings per share declined from $1.2177 to $1.0407, and operating cash flow declined 12.23% from $4.01B to $3.52B.
B
Buy 1/16/2019Upgraded
The Procter & Gamble Company (PG) was upgraded to B from B- on 1/16/2019 due to a large increase in the total return index, volatility index and growth index. Earnings per share increased from $0.7041 to $1.2247, EBIT increased 14.21% from $3.23B to $3.69B, and total revenue increased 1.13% from $16.5B to $16.69B.
B
Buy 9/28/2018Upgraded
The Procter & Gamble Company (PG) was upgraded to B- from C+ on 9/28/2018 due to an increase in the volatility index and total return index.
C
Hold 9/5/2018Upgraded
The Procter & Gamble Company (PG) was upgraded to C+ from C on 9/5/2018 due to an increase in the growth index and volatility index. Operating cash flow increased 25.23% from $3.35B to $4.2B, and total revenue increased 1.36% from $16.28B to $16.5B.
C
Hold 3/22/2018Downgrade
The Procter & Gamble Company (PG) was downgraded to C from C+ on 3/22/2018 due to a noticeable decline in the total return index, volatility index and solvency index.
C
Hold 1/25/2018Downgrade
The Procter & Gamble Company (PG) was downgraded to C+ from B- on 1/25/2018 due to a major decline in the valuation index, growth index and total return index. Earnings per share declined from $1.0604 to $0.9346.
B
Buy 1/9/2018Downgrade
The Procter & Gamble Company (PG) was downgraded to B- from B on 1/9/2018 due to a decline in the total return index, volatility index and valuation index.
B
Buy 12/13/2017Upgraded
The Procter & Gamble Company (PG) was upgraded to B from B- on 12/13/2017 due to an increase in the total return index and volatility index.
B
Buy 11/13/2017Downgrade
The Procter & Gamble Company (PG) was downgraded to B- from B on 11/13/2017 due to a large decline in the volatility index and total return index.
B
Buy 4/28/2017Downgrade
The Procter & Gamble Company (PG) was downgraded to B from B+ on 4/28/2017 due to a noticeable decline in the growth index. Earnings per share declined from $2.8766 to $0.9322, EBIT declined 13.16% from $4.05B to $3.52B, and total revenue declined 7.42% from $16.86B to $15.61B.
B
Buy 4/24/2017Upgraded
The Procter & Gamble Company (PG) was upgraded to B+ from B on 4/24/2017 due to a large increase in the total return index, volatility index and growth index.
B
Buy 2/6/2017Upgraded
The Procter & Gamble Company (PG) was upgraded to B from B- on 2/6/2017 due to a noticeable increase in the valuation index, volatility index and growth index. Earnings per share increased from $0.9614 to $2.8766, EBIT increased 3.29% from $3.92B to $4.05B, and total revenue increased 2.05% from $16.52B to $16.86B.
B
Buy 12/5/2016Upgraded
The Procter & Gamble Company (PG) was upgraded to B- from C+ on 12/5/2016 due to an increase in the volatility index, valuation index and dividend index.
C
Hold 11/14/2016Downgrade
The Procter & Gamble Company (PG) was downgraded to C+ from B- on 11/14/2016 due to a decline in the volatility index and total return index.
B
Buy 11/11/2016Downgrade
The Procter & Gamble Company (PG) was downgraded to B- from B on 11/11/2016 due to a noticeable decline in the total return index and volatility index.
B
Buy 10/27/2016Upgraded
The Procter & Gamble Company (PG) was upgraded to B from B- on 10/27/2016 due to a noticeable increase in the growth index and total return index. Earnings per share increased from $0.6871 to $0.9614, EBIT increased 37.29% from $2.86B to $3.92B, and total revenue increased 2.58% from $16.1B to $16.52B.
B
Buy 8/11/2016Upgraded
The Procter & Gamble Company (PG) was upgraded to B- from C+ on 8/11/2016 due to a major increase in the growth index, total return index and valuation index. Total revenue increased 2.2% from $15.76B to $16.1B.
C
Hold 4/28/2016Downgrade
The Procter & Gamble Company (PG) was downgraded to C+ from B- on 4/28/2016 due to a major decline in the growth index, efficiency index and solvency index. Net income declined 14.22% from $3.21B to $2.75B, earnings per share declined from $1.1192 to $0.97, and EBIT declined 12.8% from $4.06B to $3.54B.
B
Buy 1/28/2016Upgraded
The Procter & Gamble Company (PG) was upgraded to B- from C+ on 1/28/2016 due to an increase in the valuation index, growth index and volatility index. Operating cash flow increased 26.63% from $3.54B to $4.48B, earnings per share increased from $0.9072 to $1.1192, and EBIT increased 4.13% from $3.9B to $4.06B.
C
Hold 1/15/2016Downgrade
The Procter & Gamble Company (PG) was downgraded to C+ from B- on 1/15/2016 due to a noticeable decline in the total return index and volatility index.
B
Buy 12/31/2015Upgraded
The Procter & Gamble Company (PG) was upgraded to B- from C+ on 12/31/2015 due to a noticeable increase in the total return index and volatility index.
C
Hold 10/23/2015Upgraded
The Procter & Gamble Company (PG) was upgraded to C+ from C on 10/23/2015 due to a noticeable increase in the growth index, valuation index and solvency index. Earnings per share increased from $0.17 to $0.9071, and EBIT increased 31.88% from $2.96B to $3.9B.
C
Hold 10/12/2015Downgrade
The Procter & Gamble Company (PG) was downgraded to C from C+ on 10/12/2015 due to a decline in the valuation index, total return index and dividend index.
C
Hold 9/1/2015Upgraded
The Procter & Gamble Company (PG) was upgraded to C+ from C on 9/1/2015 due to an increase in the valuation index and dividend index.
C
Hold 8/17/2015Downgrade
The Procter & Gamble Company (PG) was downgraded to C from C+ on 8/17/2015 due to a noticeable decline in the growth index, total return index and valuation index. Earnings per share declined from $0.7469 to $0.17, EBIT declined 14.36% from $3.45B to $2.96B, and total revenue declined 1.94% from $18.14B to $17.79B.
C
Hold 6/8/2015Downgrade
The Procter & Gamble Company (PG) was downgraded to C+ from B- on 6/8/2015 due to a decline in the volatility index and total return index.
B
Buy 4/24/2015Downgrade
The Procter & Gamble Company (PG) was downgraded to B- from B on 4/24/2015 due to a noticeable decline in the volatility index, valuation index and efficiency index. Net income declined 9.23% from $2.37B to $2.15B, and total capital declined 3.47% from $99.27B to $95.82B.
B
Buy 4/25/2014Downgrade
The Procter & Gamble Company (PG) was downgraded to B from B+ on 4/25/2014 due to a substantial decline in the growth index, volatility index and total return index. Earnings per share declined from $1.1786 to $0.9015, EBIT declined 22.33% from $4.73B to $3.67B, and total revenue declined 7.72% from $22.28B to $20.56B.
Weiss Ratings